Financial & Tax Architects, LLC Astrazeneca PLC Transaction History

Financial & Tax Architects, LLC

  • $389 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023
BUY
$69.91 - $75.81 $36,423 - $39,497
521 Added 6.83%
8,153 $584 Million
Q1 2023

Apr 26, 2023
BUY
$63.15 - $71.6 $42,247 - $47,900
669 Added 9.61%
7,632 $530 Million
Q4 2022

Feb 09, 2023
BUY
$54.21 - $70.44 $377,464 - $490,473
6,963 New
6,963 $481 Million

Others Institutions Holding AZN

# of Institutions
1,361
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Financial & Tax Architects, LLC Portfolio

Follow Financial & Tax Architects, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial & Tax Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial & Tax Architects, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email